טוען...
Value based pricing for NHS drugs: an opportunity not to be missed?
The policy debate about price, value, and innovation in pharmaceuticals is at a critical stage for the NHS. Claxton and colleagues describe the key principles of value based pricing and consider some of the concerns about such a scheme
שמור ב:
| Main Authors: | , , , , , , |
|---|---|
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
BMJ Publishing Group Ltd.
2008
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2223028/ https://ncbi.nlm.nih.gov/pubmed/18244997 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bmj.39434.500185.25 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|